Results 131 to 140 of about 1,120,480 (196)

Nipah virus preparedness in a One Health framework: Implications for Europe. [PDF]

One Health
Grzybek M, Mundt B, Kant R, Bogacka A.
europepmc   +1 more source

Discovery of Quercetin as a Potential Entry Inhibitor of Nipah Virus: A Path Toward Antiviral Therapy. [PDF]

Int J Mol Sci
Alam MM, Rahman MM, Raj KH, Nahid AH, Saha P, Hossain A, Amaya M, Laing ED, Satter SM, Broder CC, Hossain ME, Rahman MZ.   +11 more
europepmc   +1 more source

The potential threat of Nipah virus

Clinical Medicine, 2022
openaire   +2 more sources

Computational design of immunogenic peptide-ligand conjugates for targeted therapy against Nipah virus infection. [PDF]

Front Bioinform
Jena SP, Nayak P, Adithyan MA, Morey M, Tharsini RV, Gopalakrishnan AV, Pal K, Prince SE.   +7 more
europepmc   +1 more source

Accelerating Nipah virus vaccine development to prevent future global outbreaks. [PDF]

Ann Med Surg (Lond)
Ahmed Q, Shoukat SEA, Sohail F, Khan MH.
europepmc   +1 more source

Nipah Virus Encephalitis: Pathogenetic Aspects and Current Therapeutic Strategies. [PDF]

Pathogens
Scotto G, Fazio V, Moula AM, Bavisetty SCB, Franza A, Massa S.   +5 more
europepmc   +1 more source

Multi-epitope design against emerging nipah virus towards peptide vaccine development. [PDF]

Bioinformation
Kumar MN, Kumar DM, B V N V B, Annam V, Pradhan A, Sulthana SR, Singam Y.   +6 more
europepmc   +1 more source

[Nipah virus infections].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003
openaire   +2 more sources

Nipah virus infects the brain and triggers neuronal and glial damage in a hamster model. [PDF]

J Neuroinflammation
Valerdi K, Saito T, Paroha R, Littlefield K, Plante J, Plante K, Valdebenito S, Maruyama J, Eugenin E.   +8 more
europepmc   +1 more source

In silico study of 14-3-3σ and Nipah virus W proteins interaction. [PDF]

Sci Rep
Griaznova L, Arakelov V, Arakelov G, Nazaryan K.   +3 more
europepmc   +1 more source